Vasco Moscovici da Cruz1, Lucimara Camalionte2, Pedro Caruso3. 1. ICU, AC Camargo Cancer Center, São Paulo, Brazil vasco.cruz@accamargo.org.br. 2. ICU, AC Camargo Cancer Center, São Paulo, Brazil. 3. ICU, AC Camargo Cancer Center, São Paulo, Brazil Disciplina de Pneumologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Abstract
BACKGROUND: Management of critically ill patients involves weighing potential benefit of advanced life support against preserving quality of life, avoidance of futile measures and rational use of resources. AIM: Our study aims to identify the predisposing factors involved in the institution and maintenance of futile intensive care support in terminally ill cancer patients in whom no additional treatment for the malignant disease would be offered. DESIGN: We retrospectively analysed the medical records of patients who died in a tertiary cancer hospital (Hospital A C Camargo, São Paulo, Brazil) during an eight month period. Medical futility was defined when a patient, despite having been stated in the hospital records as having no possible lifespan extending treatment, was admitted to intensive care and received advanced life support. These cases were compared to controls who received palliative end-of-life care. RESULTS: Three hundred and forty-seven deaths were recorded, of which 238 did not undergo futile treatment, 71 received full code treatment and 38 received futile treatments. Statistically significant predisposing factors for medical futility were, in our analysis, lack of palliative care team consultation (p < 0.001) and hematologic malignancy (p = 0.036). Qualitative analysis of medical records traced futile treatments to physicians' lacking proactive attitudes in considering prognosis and talking to families. CONCLUSIONS: We conclude that a significant minority of end-of-life care consists of futile treatments. Strategies to increase Oncologists' and Critical Care specialists' alertness to these issues and expand indications of Palliative Care consultations are recommended.
BACKGROUND: Management of critically illpatients involves weighing potential benefit of advanced life support against preserving quality of life, avoidance of futile measures and rational use of resources. AIM: Our study aims to identify the predisposing factors involved in the institution and maintenance of futile intensive care support in terminally ill cancerpatients in whom no additional treatment for the malignant disease would be offered. DESIGN: We retrospectively analysed the medical records of patients who died in a tertiary cancer hospital (Hospital A C Camargo, São Paulo, Brazil) during an eight month period. Medical futility was defined when a patient, despite having been stated in the hospital records as having no possible lifespan extending treatment, was admitted to intensive care and received advanced life support. These cases were compared to controls who received palliative end-of-life care. RESULTS: Three hundred and forty-seven deaths were recorded, of which 238 did not undergo futile treatment, 71 received full code treatment and 38 received futile treatments. Statistically significant predisposing factors for medical futility were, in our analysis, lack of palliative care team consultation (p < 0.001) and hematologic malignancy (p = 0.036). Qualitative analysis of medical records traced futile treatments to physicians' lacking proactive attitudes in considering prognosis and talking to families. CONCLUSIONS: We conclude that a significant minority of end-of-life care consists of futile treatments. Strategies to increase Oncologists' and Critical Care specialists' alertness to these issues and expand indications of Palliative Care consultations are recommended.
Authors: Libby Sallnow; Richard Smith; Sam H Ahmedzai; Afsan Bhadelia; Charlotte Chamberlain; Yali Cong; Brett Doble; Luckson Dullie; Robin Durie; Eric A Finkelstein; Sam Guglani; Melanie Hodson; Bettina S Husebø; Allan Kellehear; Celia Kitzinger; Felicia Marie Knaul; Scott A Murray; Julia Neuberger; Seamus O'Mahony; M R Rajagopal; Sarah Russell; Eriko Sase; Katherine E Sleeman; Sheldon Solomon; Ros Taylor; Mpho Tutu van Furth; Katrina Wyatt Journal: Lancet Date: 2022-02-01 Impact factor: 79.321
Authors: Xing J Lee; Alison Farrington; Hannah Carter; Carla Shield; Nicholas Graves; Steven M McPhail; Gillian Harvey; Ben P White; Lindy Willmott; Magnolia Cardona; Ken Hillman; Leonie Callaway; Adrian G Barnett Journal: BMC Geriatr Date: 2020-07-29 Impact factor: 3.921
Authors: Paul R Duberstein; Michael Chen; Michael Hoerger; Ronald M Epstein; Laura M Perry; Sule Yilmaz; Fahad Saeed; Supriya G Mohile; Sally A Norton Journal: J Pain Symptom Manage Date: 2019-10-19 Impact factor: 3.612